OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
Journal article published in 2021 by
Guillaume Beyrend 
,
Tetje C. van der Sluis,
Esmé T. I. van der Gracht,
Tamim Abdelaal,
Simon P. Jochems,
Robert A. Belderbos,
Thomas H. Wesselink,
Suzanne van Duikeren,
Floortje J. van Haften,
Anke Redeker,
Elham Beyranvand Nejad,
Elham Beyranvand Nejad,
Marcel G. M. Camps,
Kees Lmc Franken,
Margot M. Linssen
and other authors.
,
Tetje C. van der Sluis,
Esmé T. I. van der Gracht,
Tamim Abdelaal,
Simon P. Jochems,
Robert A. Belderbos,
Thomas H. Wesselink,
Suzanne van Duikeren,
Floortje J. van Haften,
Anke Redeker,
Elham Beyranvand Nejad,
Elham Beyranvand Nejad,
Marcel G. M. Camps,
Kees Lmc Franken,
Margot M. Linssen
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 